XOMA CORPORATION (FKA XOMA (US) LLC) for XOMA CORPORATION (FKA XOMA (US) LLC)
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues relating to the Ways and Means Discussion Draft, Tax Reform Act of 2014, all provisions relating to an orphan drug tax credit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BETH RADA | — |
Health Issues HCR
Issues regarding the implementation of PL 111-148 "Patient Protection and Affordable Care Act of 2010," all provisions. HR 460 "Patients' Access to Treatment Act of 2013," all provisions pertaining to coverage and reimbursement for specialty tier drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BETH RADA | — |
Medicare/Medicaid MMM
HR 4160 "The Keep the Promise to Seniors Act of 2014," all provisions relating to protected classes and non-interference provision.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BETH RADA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.